ALESKANDARANY, M. A., VANDENBERGHE, M. E., MARCHIO, C., ELLIS, I. O., SAPINO, A. and RAKHA, E. A., 2018. Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine: Pathobiology Pathobiology. AL-SUBHI, N., ALI, R., ABDEL-FATAH, T., MOSELEY, P. M., CHAN, S. Y. T., GREEN, A. R., ELLIS, I. O., RAKHA, E. A. and MADHUSUDAN, S., 2018. Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy: Breast Cancer Res Treat Breast Cancer Res Treat. CRAZE, M. L., CHEUNG, H., JEWA, N., COIMBRA, N. D. M., SORIA, D., EL-ANSARI, R., ALESKANDARANY, M. A., WAI CHENG, K., DIEZ-RODRIGUEZ, M., NOLAN, C. C., ELLIS, I. O., RAKHA, E. A. and GREEN, A. R., 2018. MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer: Br J Cancer Br J Cancer. 118(2), 258-265 EBILI, H. O., IYAWE, V. O., ADELEKE, K. R., SALAMI, B. A., BANJO, A. A., NOLAN, C., RAKHA, E., ELLIS, I., GREEN, A. and AGBOOLA, A. O. J., 2018. Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients: Mol Diagn Ther Mol Diagn Ther. 22(1), 79-90 EL ANSARI, R., MCINTYRE, A., CRAZE, M. L., ELLIS, I. O., RAKHA, E. A. and GREEN, A. R., 2018. Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations: Histopathology Histopathology. 72(2), 183-190 GONG, C., MAN, E. P., TSOI, H., LEE, T. K., LEE, P., MA, S. T., WONG, L. S., LUK, M. Y., RAKHA, E. A., GREEN, A. R., ELLIS, I. O., CHEUNG, K. L. and KHOO, U. S., 2018. BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen Resistant Breast Cancer: Clin Cancer Res Clin Cancer Res. PU, X., STORR, S. J., AHMAD, N. S., RAKHA, E. A., GREEN, A. R., ELLIS, I. O. and MARTIN, S. G., 2018. High nuclear MSK1 is associated with longer survival in breast cancer patients: J Cancer Res Clin Oncol J Cancer Res Clin Oncol. 144(3), 509-517 RIDA, P., OGDEN, A., ELLIS, I. O., VARGA, Z., WOLFF, A. C., TRAINA, T. A., HATZIS, C., PALMER, J. R., AMBROSONE, C. B., LEHMANN, B. D., NANDA, R., MONTGOMERY RICE, V., BRAWLEY, O. W., TORRES, M. A., RAKHA, E. and ANEJA, R., 2018. First international TNBC conference meeting report: Breast Cancer Res Treat Breast Cancer Res Treat. ROXANIS, I., COLLING, R., KARTSONAKI, C., GREEN, A. R. and RAKHA, E. A., 2018. The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis: Breast Cancer Res Breast Cancer Res. 20(1), 11 GEYER, FELIPE C, LI, ANQI, PAPANASTASIOU, ANASTASIOS D, SMITH, ALISON, SELENICA, PIER, BURKE, KATHLEEN A, EDELWEISS, MARCIA, WEN, HUEI-CHI, PISCUOGLIO, SALVATORE, SCHULTHEIS, ANNE M, MARTELOTTO, LUCIANO G, PAREJA, FRESIA, KUMAR, RAHUL, BRANDES, ALISSA, FAN, DAN, BASILI, THAIS, DA CRUZ PAULA, ARNAUD, LOZADA, JOHN R, BLECUA, PEDRO, MUENST, SIMONE, JUNGBLUTH, ACHIM A, FOSCHINI, MARIA P, WEN, HANNAH Y, BROGI, EDI, PALAZZO, JUAN, RUBIN, BRIAN P, NG, CHARLOTTE K Y, NORTON, LARRY, VARGA, ZSUZSANNA, ELLIS, IAN O, RAKHA, EMAD A, CHANDARLAPATY, SARAT, WEIGELT, BRITTA and REIS-FILHO, JORGE S, 2018. Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas. Nature communications. 9(1), 1816
ROXANIS, I., COLLING, R., KARTSONAKI, C., GREEN, A. R. and RAKHA, E. A., 2018. The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis BREAST CANCER RESEARCH. 20, LUAN, HAITAO, MOHAPATRA, BHOPAL, BIELECKI, TIMOTHY A, MUSHTAQ, INSHA, MIRZA, SAMEER, JENNINGS, TAMEKA A, CLUBB, ROBERT J, AN, WEI, AHMED, DENA, EL ANSARI, ROKAYA, STORCK, MATTHEW D, MISHRA, NITISH K, GUDA, CHITTIBABU, SHEININ, YURI M, MEZA, JANE L, RAJA, SRIKUMAR, RAKHA, EMAD A, BAND, VIMLA and BAND, HAMID, 2018. Loss of the nuclear pool of ubiquitin ligase CHIP/STUB1 in breast cancer unleashes the MZF1-cathepsin pro-oncogenic program. Cancer research.
KADER, TANJINA, HILL, PRUE, RAKHA, EMAD A, CAMPBELL, IAN G and GORRINGE, KYLIE L, 2018. Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape. Breast cancer research : BCR. 20(1), 39
JOSEPH, CHITRA, MACNAMARA, OLIVIA, CRAZE, MADELEINE, RUSSELL, ROSLIN, PROVENZANO, ELENA, NOLAN, CHRISTOPHER C., DIEZ-RODRIGUEZ, MARIA, SONBUL, SULTAN N., ALESKANDARANY, MOHAMMED A., GREEN, ANDREW R., RAKHA, EMAD A., ELLIS, IAN O. and MUKHERJEE, ABHIK, 2018. Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER plus luminal subtypes BRITISH JOURNAL OF CANCER. 118(8), 1142-1151 DESMEDT, CHRISTINE, SALGADO, ROBERTO, FORNILI, MARCO, PRUNERI, GIANCARLO, VAN DEN EYNDEN, GERT, ZOPPOLI, GABRIELE, ROTHE, FRANCOISE, BUISSERET, LAURENCE, GARAUD, SOIZIC, WILLARD-GALLO, KAREN, BROWN, DAVID, BARECHE, YACINE, ROUAS, GHIZLANE, GALANT, CHRISTINE, BERTUCCI, FRANCOIS, LOI, SHERENE, VIALE, GIUSEPPE, DI LEO, ANGELO, GREEN, ANDREW R, ELLIS, IAN O, RAKHA, EMAD A, LARSIMONT, DENIS, BIGANZOLI, ELIA and SOTIRIOU, CHRISTOS, 2018. Immune Infiltration in Invasive Lobular Breast Cancer. Journal of the National Cancer Institute.
PU X, STORR SJ, ZHANG Y, RAKHA EA, GREEN AR, ELLIS IO and MARTIN SG, 2017. Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival. Apoptosis : an international journal on programmed cell death. 22, 3 METZLER VM, DE BROT S, ROBINSON RS, JEYAPALAN JN, RAKHA E, WALTON T, GARDNER DS, LUND EF, WHITCHURCH J, HAIGH D, LOCHRAY JM, ROBINSON BD, ALLEGRUCCI C, FRAY RG, PERSSON JL, ØDUM N, MIFTAKHOVA RR, RIZVANOV AA, HUGHES IA, TADOKORO-CUCCARO R, HEERY DM, RUTLAND CS and MONGAN NP, 2017. Androgen dependent mechanisms of pro-angiogenic networks in placental and tumor development. Placenta. S0143-4004(17), 30164-9 MUFTAH AA, ALESKANDARANY MA, AL-KAABI MM, SONBUL SN, DIEZ-RODRIGUEZ M, NOLAN CC, CALDAS C, ELLIS IO, RAKHA EA and GREEN AR, 2017. Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections. Breast cancer research and treatment. (In Press.)
CHRYSANTHOU E, GORRINGE KL, JOSEPH C, CRAZE M, NOLAN CC, DIEZ-RODRIGUEZ M, GREEN AR, RAKHA EA, ELLIS IO and MUKHERJEE A, 2017. Phenotypic characterisation of breast cancer: the role of CDC42. Breast cancer research and treatment. SONBUL SN, GORRINGE KL, ALESKANDARANY MA, MUKHERJEE A, GREEN AR, ELLIS IO and RAKHA EA, 2017. Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma. The journal of pathology. Clinical research. 3(2), 105-114 MILIGY I, MOHAN P, GABER A, ALESKANDARANY MA, NOLAN CC, DIEZ-RODRIGUEZ M, MUKHERJEE A, CHAPMAN C, ELLIS IO, GREEN AR and RAKHA EA, 2017. Prognostic significance of Tumour infiltrating B-Lymphocytes in Breast Ductal Carcinoma in Situ. Histopathology. 71(2), :258-268 GREEN AR, ALESKANDARANY MA, ALI R, HODGSON EG, ATABANI S, DE SOUZA K, RAKHA EA, ELLIS IO and MADHUSUDAN S, 2017. Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in Breast Cancers. Cancer immunology research. 5(4), 292-299 CANDIDO DOS REIS FJ, WISHART GC, DICKS EM, GREENBERG D, RASHBASS J, SCHMIDT MK, VAN DEN BROEK AJ, ELLIS IO, GREEN A, RAKHA E, MAISHMAN T, ECCLES DM and PHAROAH PDP, 2017. An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation. Breast cancer research : BCR. 19(1), 58 TOSS M, MILIGY I, THOMPSON AM, KHOUT H, GREEN AR, ELLIS IO and RAKHA EA, 2017. Current trials to reduce surgical intervention in ductal carcinoma in situ of the breast: Critical review. Breast (Edinburgh, Scotland). 35, 151-156 (In Press.)
KLIMOV S, RIDA PC, ALESKANDARANY MA, GREEN AR, ELLIS IO, JANSSEN EA, RAKHA EA and ANEJA R, 2017. Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers. British journal of cancer. (In Press.)
CRAZE ML, CHEUNG H, JEWA N, COIMBRA NDM, SORIA D, EL-ANSARI R, ALESKANDARANY MA, WAI CHENG K, DIEZ-RODRIGUEZ M, NOLAN CC, ELLIS IO, RAKHA EA and GREEN AR, 2017. MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer. British journal of cancer. (In Press.)
NAIDOO K, WAI PT, MAGUIRE SL, DALEY F, HAIDER S, KRIPLANI D, CAMPBELL J, MIRZA H, GRIGORIADIS A, TUTT A, MOSELEY PM, ABDEL-FATAH TMA, CHAN SY, MADHUSUDAN S, RAKHA EA, ELLIS IO, LORD CJ, YUAN Y, GREEN AR and NATRAJAN R, 2017. Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response Targeted Therapies in Breast Cancer. Molecular cancer therapeutics. (In Press.)
REIS-FILHO JS, GEYER FC, WEIGELT B, RAKHA EA, ELLIS IO and SCHNITT SJ, 2017. Reply to Rosen. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 30(10), 1505-1506 GEYER FC, PAREJA F, WEIGELT B, RAKHA E, ELLIS IO, SCHNITT SJ and REIS-FILHO JS, 2017. The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions. The American journal of pathology. 187(10), 2139-2151 MITTAL K, CHOI DH, OGDEN A, DONTHAMSETTY S, MELTON BD, GUPTA MV, PANNU V, CANTUARIA G, VARAMBALLY S, REID MD, JONSDOTTIR K, JANSSEN EA, ALESKANDARANY MA, ELLIS IO, RAKHA EA, RIDA PC and ANEJA R, 2017. Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells. Scientific reports. 7, 43984 EBILI HO, IYAWE VO, ADELEKE KR, SALAMI BA, BANJO AA, NOLAN C, RAKHA E, ELLIS I, GREEN A and AGBOOLA AOJ, 2017. Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients. Molecular diagnosis & therapy. (In Press.)
DAHLSTROM JE, RAKHA EA, LAKHANI SR and SCHNITT SJ, 2017. Current topics in breast pathology: expert perspectives. Pathology. 49(2), 109-110 MITTAL, KARUNA, CHOI, DA HOON, OGDEN, ANGELA, MELTON, BRIAN D., GUPTA, MEENAKSHI VIJ, REID, MICHELLE D., JONSDOTTIR, KRISTIN, JANSSEN, EMIEL A., ALESKANDARANY, MOHAMMAD A., ELLIS, IAN O., RAKHA, ERNAD A., RIDA, PADMASHREE C. G. and ANEJA, RITU, 2017. Association of hypoxia-induced centrosome amplification with clinical outcomes in triple-negative breast cancer. JOURNAL OF CLINICAL ONCOLOGY. 35, OGDEN, ANGELA, BHATTARAI, SHRISTI, GREEN, ANDREW R., ALESKANDARANY, MOHAMMED A., RAKHA, EMAD A., ELLIS, IAN O., LI, XIAOXIAN (BILL), KRISHNARNURTI, UMA, JANSSEN, EMIEL A., JONSDOTTIR, KRISTIN, REID, MICHELLE D., RIDA, PADMASHREE C. G. and ANEJA, RITU, 2017. HER3-EGFR score to predict clinical outcomes in triple-negative breast cancer. JOURNAL OF CLINICAL ONCOLOGY. 35, CHOUDHARY, ISHITA, KLIMOV, SERGEY, RIDA, PADMASHREE C. G., OGDEN, ANGELA, GREEN, ANDREW R., ALESKANDARANY, MOHAMMED A., RAKHA, EMAD A., ELLIS, IAN O., BIGANZOLI, ELIA, SARKAR, SUROJIT, KALIA, VANDANA and ANEJA, RITU, 2017. Dynamic relationship between cycling kinetics of triple-negative breast cancer and tumor infiltrating immune cells JOURNAL OF CLINICAL ONCOLOGY. 35, MOHAMMED, R. A. A., EL-DEEK MOHAMED, H., GREEN, A., ALESKANDARANY, M. A., ELLIS, I. O. and RAKHA, E., 2017. Clinicopathological Characteristics of Triple Negative-Basal Breast Cancer: A Comparative Study Between Egyptian and British Patients JOURNAL OF PATHOLOGY. 243, S24-S24
ALIYEVA, T. A., JOSEPH, C., PROVENZANO, E., RUSSELL, R., CALDAS, C., SONBUL, S., NOLAN, C., GREEN, A. R., RAKHA, E. A., ELLIS, I. O. and MUKHERJEE, A., 2017. Loss of MED23 Leads to Poor Prognosis in Invasive Breast Cancer JOURNAL OF PATHOLOGY. 243, S17-S17
OJIEGBE, S., JOSEPH, C., PROVENZANO, E., CALDAS, C., NOLAN, C., GREEN, A. R., RAKHA, E., ELLIS, I. O. and MUKHERJEE, A., 2017. Elevated Expression of STK3 mRNA and Protein is Associated with Poor Outcome in Invasive Breast Cancer JOURNAL OF PATHOLOGY. 243, S16-S16
EL-ANSARI, R., ALESKANDARANY, M. A., CHENG, K. W., DIEZ-RODRIGUEZ, M., NOLAN, C. C., CALDAS, C., ELLIS, I. O., RAKHA, E. A. and GREEN, A. R., 2017. Glutamine Transporters SLC1A5 and SLC7A5 are Key Therapeutic Targets in Luminal B Breast Cancer JOURNAL OF PATHOLOGY. 243, S16-S16
JOSEPH, C., CRAZE, M., NOLAN, C., DIEZ-RODRIGUEZ, M., GREEN, A. R., RAKHA, E., ELLIS, I. O. and MUKHERJEE, A., 2017. FOXP1 Expression Correlates with Better Prognosis in Invasive Breast Cancer Including the ER-Positive Luminal Subtype JOURNAL OF PATHOLOGY. 243, S17-S17
ALTHOBITI, M., ALESKANDARANY, M. A., GREEN, A. R., JOSEPH, C., RODRIGUEZ, M. DIEZ, NOLAN, C. C., ELLIS, I. O. and RAKHA, E. A., 2017. The Heterogeneity of Tumour Infiltrating Lymphocytes and its Effect on Patient Outcome JOURNAL OF PATHOLOGY. 243, S17-S17
OJIEGBE, S., JOSEPH, C., PROVENZANO, E., CALDAS, C., NOLAN, C., GREEN, A. R., RAKHA, E., ELLIS, I. O. and MUKHERJEE, A., 2017. Cell Division Cycle 25C (CDC25C) Expression Confers Poor Prognosis in Invasive Breast Cancer JOURNAL OF PATHOLOGY. 243, S16-S16
MILIGY, I., GABER, A., RODRIGUEZ, M. DIEZ, NOLAN, C. C., GREEN, A. R., ELLIS, I. O. and RAKHA, E. A., 2017. Thioredoxin Interacting Protein (TXNIP) is an Independent Prognostic Factor in Breast Ductal Carcinoma In Situ JOURNAL OF PATHOLOGY. 243, S10-S10
SONBUL, S. N., GREEN, A. R., RUEDA, O. M., MUKHERJEE, A., ALESKANDARANY, M. A., RUSSELL, R., PROVENZANO, E., CALDAS, C., ELLIS, I. O. and RAKHA, E. A., 2017. Lympho-Vascular Invasion (LVI) Supervised Transcriptomic Study Disclosed Clusters of Genes with Significant Prognostic Importance in Invasive Breast Carcinoma JOURNAL OF PATHOLOGY. 241, S8-S8
ALTHOBITI, M., ALESKANDARANY, M. A., GREEN, A. R., RODRIGUEZ, M. DIEZ, NOLAN, C. C., BALL, G. R., ELLIS, I. O. and RAKHA, E. A., 2017. Zinc Finger Protein 22: a Potential Metastatic Progression Biomarker in Invasive Breast Cancer JOURNAL OF PATHOLOGY. 241, S9-S9
ROXANIS, IOANNIS, COLLING, RICHARD, RAKHA, EMAD A., GREEN, ANDREW, RITTSCHER, JENS, CONCEICAO, RAQUEL C., ROSS, AIDAN, NICHOLSON, GEORGE and HOLMES, CHRIS, 2017. Digital Analysis of Tumour Microarchitecture as an Independent Prognostic Tool in Breast Cancer MODERN PATHOLOGY. 30, 68A-68A
ALESKANDARANY, M. A., SONBUL, S., SURRIDGE, R., MUKHERJEE, A., CALDAS, C., DIEZ-RODRIGUEZ, M., ASHANKYTY, I., ALBRAHIM, K. I., ELMOUNA, A. M., ANEJA, R., MARTIN, S. G., ELLIS, I. O., GREEN, A. R. and RAKHA, E. A., 2017. Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer: Br J Cancer Br J Cancer. 117(8), 1176-1184 RAKHA, E. A., MILIGY, I. M., GORRINGE, K. L., TOSS, M. S., GREEN, A. R., FOX, S. B., SCHMITT, F. C., TAN, P. H., TSE, G. M., BADVE, S., DECKER, T., VINCENT-SALOMON, A., DABBS, D. J., FOSCHINI, M. P., MORENOM, F., WENTAO, Y., GEYER, F. C., REIS-FILHO, J. S., PINDER, S. E., LAKHANI, S. R. and ELLIS, I. O., 2017. Invasion in breast lesions: the role of the epithelial-stroma barrier: Histopathology Histopathology. REIS-FILHO, J. S., GEYER, F. C., WEIGELT, B., RAKHA, E. A., ELLIS, I. O. and SCHNITT, S. J., 2017. Reply to Rosen: Mod Pathol Mod Pathol. 30(10), 1505-1506 GUERINI-ROCCO, ELENA, PISCUOGLIO, SALVATORE, NG, CHARLOTTE K. Y., GEYER, FELIPE C., DE FILIPPO, MARIA R., EBERLE, CAREY A., AKRAM, MUZAFFAR, FUSCO, NICOLA, ICHIHARA, SHU, SAKR, RITA A., YATABE, YASUSHI, VINCENT-SALOMON, ANNE, RAKHA, EMAD A., ELLIS, IAN O., WEN, Y. HANNAH, WEIGELT, BRITTA, SCHNITT, STUART J. and REIS-FILHO, JORGE S., 2016. Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations JOURNAL OF PATHOLOGY. 238(5), 677-688 ALESKANDARANY, MOHAMMED A., AGARWAL, DEVIKA, NEGM, OLA H., BALL, GRAHAM, ELMOUNA, AHMED, ASHANKYTY, IBRAHEEM, NUGLOZEH, EDEM, FAZALUDEEN, MOHAMMAD F., DIEZ-RODRIGUEZ, MARIA, NOLAN, CHRISTOPHER C., TIGHE, PATRICK J., GREEN, ANDREW R., ELLIS, IAN O. and RAKHA, EMAD A., 2016. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts BREAST CANCER RESEARCH AND TREATMENT. 156(1), 9-20 GREEN, ANDREW R., SORIA, D., POWE, D. G., NOLAN, C. C., ALESKANDARANY, M., SZASZ, M. A., TOKES, A. M., BALL, G. R., GARIBALDI, J. M., RAKHA, E. A., KULKA, J. and ELLIS, I. O., 2016. Nottingham prognostic index plus (NPI plus ) predicts risk of distant metastases in primary breast cancer BREAST CANCER RESEARCH AND TREATMENT. 157(1), 65-75 ARORA, ARVIND, AGARWAL, DEVIKA, ABDEL-FATAH, TAREK M. A., LU, HUIMING, CROTEAU, DEBORAH L., MOSELEY, PAUL, ALESKANDARANY, MOHAMMED A., GREEN, ANDREW R., BALL, GRAHAM, RAKHA, EMAD A., CHAN, STEPHEN Y. T., ELLIS, IAN O., WANG, LISA L., ZHAO, YONGLIANG, BALAJEE, ADAYABALAM S., BOHR, VILHELM A. and MADHUSUDAN, SRINIVASAN, 2016. RECQL4 helicase has oncogenic potential in sporadic breast cancers JOURNAL OF PATHOLOGY. 238(4), 495-501 ALBANGHALI, MOHAMMAD, GREEN, ANDREW, RAKHA, EMAD, ALESKANDARANY, MOHAMED, NOLAN, CHRIS, ELLIS, IAN and CHEUNG, KWOK-LEUNG, 2016. Construction of tissue microarrays from core needle biopsies - a systematic literature review HISTOPATHOLOGY. 68(3), 323-332 KLIMOV, SERGEY, GREEN, ANDREW, ALESKANDARANY, MOHAMMED A., RAKHA, EMAD, ELLIS, IAN O., REID, MICHELLE, RIDA, PADMASHREE C. G. and ANEJA, RITU, 2016. Predicting Metastatic Site of Triple Negative Breast Cancers Using Immunohistochemical Biomarkers MODERN PATHOLOGY. 29, 51A-51A
KLIMOV, SERGEY, GREEN, ANDREW, ALESKANDARANY, MOHAMMED A., RAKHA, EMAD, ELLIS, IAN O., CANTUARIA, GUILHERME, AGBOOLA, AYODEJI O., REID, MICHELLE, LI, XIAOXIAN, RIDA, PADMASHREE C. G. and ANEJA, RITU, 2016. A Novel Risk-Predictive Metric Stratifies Triple-Negative Breast Cancers Based on Cell Cycling Kinetics MODERN PATHOLOGY. 29, 51A-51A
KLIMOV, SERGEY, GREEN, ANDREW, ALESKANDARANY, MOHAMMED A., RAKHA, EMAD, ELLIS, IAN O., REID, MICHELLE, RIDA, PADMASHREE C. G. and ANEJA, RITU, 2016. Predicting Metastatic Site of Triple Negative Breast Cancers Using Immunohistochemical Biomarkers LABORATORY INVESTIGATION. 96, 51A-51A
ARORA, ARVIND, ABDEL-FATAH, TAREK M. A., AGARWAL, DEVIKA, DOHERTY, RACHEL, CROTEAU, DEBORAH L., MOSELEY, PAUL M., HAMEED, KHALID, GREEN, ANDREW, ALESKANDARANY, MOHAMMED A., RAKHA, EMAD A., PATTERSON, KARL, BALL, GRAHAM, CHAN, STEPHEN Y. T., ELLIS, IAN O., BOHR, VILHELM A., BRYANT, HELEN E. and MADHUSUDAN, SRINIVASAN, 2016. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers CARCINOGENESIS. 37(1), 63-71 GEYEI, FELIPE C., PISCUOGLIO, SALVATORE, NG, CHARLOTTE K. Y., GUERINI-ROCCO, ELENA, MARCHIO, CATERINA, HODI, ZSOLT, RAKHA, EMAD, ELLIS, IAN O., SCHNITT, STUART, WEIGELT, BRITTA and REIS-FILHO, JORGE S., 2016. Are Microglandular Adenosis and Breast Acinic Cell Carcinomas Related Lesions? MODERN PATHOLOGY. 29, 42A-42A
PATEL, H., ABDULJABBAR, R., LAI, C. F., PERIYASAMY, M., HARROD, A., GEMMA, C., STEEL, J., PATEL, N., BUSONERO, C., JERJEES, D., REMENYI, J., SMITH, S., GOMM, J. J., MAGNANI, L., GYORFFY, B., JONES, J. L., FULLER-PACE, F. V., SHOUSHA, S., BULUWELA, L., RAKHA, E. A., ELLIS, I. O., COOMBES, R. C. and ALI, S., 2016. CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor- positive breast cancer: Clin Cancer Res Clin Cancer Res. LANGLANDS, F., CORNFORD, E., RAKHA, E., DALL, B., GUTTERIDGE, E., DODWELL, D., SHAABAN, A. M. and SHARMA, N., 2016. Imaging overview of metaplastic carcinomas of the breast: a large study of 71 cases: Br J Radiol Br J Radiol. 20140644 GREEN, A. R., SORIA, D., POWE, D. G., NOLAN, C. C., ALESKANDARANY, M., SZASZ, M. A., TOKES, A. M., BALL, G. R., GARIBALDI, J. M., RAKHA, E. A., KULKA, J. and ELLIS, I. O., 2016. Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer: Breast Cancer Res Treat Breast Cancer Res Treat. 157(1), 65-75 FRANCIS, A., BARTLETT, J., REA, D., PINDER, S. E., STEIN, R. C., STOBART, H., PURDIE, C. A., RAKHA, E., THOMPSON, A., SHAABAN, A. M. and TRANSLATIONAL SUBGROUP OF THE, NCRI BREAST CLINICAL STUDIES GROUP, 2016. Viewpoint: Availability of oestrogen receptor and HER2 status for the breast multidisciplinary meeting discussion; time to get it right: Eur J Surg Oncol Eur J Surg Oncol. TAN, B. Y., ACS, G., APPLE, S. K., BADVE, S., BLEIWEISS, I. J., BROGI, E., CALVO, J. P., DABBS, D. J., ELLIS, I. O., EUSEBI, V., FARSHID, G., FOX, S. B., ICHIHARA, S., LAKHANI, S. R., RAKHA, E. A., REIS-FILHO, J. S., RICHARDSON, A. L., SAHIN, A., SCHMITT, F. C., SCHNITT, S. J., SIZIOPIKOU, K. P., SOARES, F. A., TSE, G. M., VINCENT-SALOMON, A. and TAN, P. H., 2016. Phyllodes tumours of the breast: a consensus review: Histopathology Histopathology. 68(1), 5-21 RAKHA, E. A., PIGERA, M., SHIN, S. J., D'ALFONSO, T., ELLIS, I. O. and LEE, A. H., 2016. Human epidermal growth factor receptor 2 testing in invasive breast cancer: should histological grade, type and oestrogen receptor status influence the decision to repeat testing?: Histopathology Histopathology. 69(1), 20-4 EBERLE, C. A., PISCUOGLIO, S., RAKHA, E. A., NG, C. K., GEYER, F. C., EDELWEISS, M., SAKR, R. A., WEIGELT, B., REIS-FILHO, J. S. and ELLIS, I. O., 2016. Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile: Histopathology Histopathology. 68(7), 1030-9 RAKHA, E. A., BADVE, S., EUSEBI, V., REIS-FILHO, J. S., FOX, S. B., DABBS, D. J., DECKER, T., HODI, Z., ICHIHARA, S., LEE, A. H., PALACIOS, J., RICHARDSON, A. L., VINCENT-SALOMON, A., SCHMITT, F. C., TAN, P. H., TSE, G. M. and ELLIS, I. O., 2016. Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management: Histopathology Histopathology. 68(1), 45-56 GREEN, ANDREW R, SORIA, DANIELE, STEPHEN, JACQUELINE, POWE, DESMOND G, NOLAN, CHRISTOPHER C, KUNKLER, IAN, THOMAS, JEREMY, KERR, GILLIAN R, JACK, WILMA, CAMERON, DAVID, PIPER, TAMMY, BALL, GRAHAM R, GARIBALDI, JONATHAN M, RAKHA, EMAD A, BARTLETT, JOHN and ELLIS, IAN O, 2016. Nottingham prognostic index plus: validation of a clinical decision making tool in breast cancer in an independent series The Journal of Pathology: Clinical Research. 2(1), 32-40 ALESKANDARANY, M. A., GREEN, A. R., ASHANKYTY, I., ELMOUNA, A., DIEZ-RODRIGUEZ, M., NOLAN, C. C., ELLIS, I. O. and RAKHA, E. A., 2016. Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer BREAST CANCER RESEARCH AND TREATMENT. 158(2), 287-295 GREEN, ANDREW R., ALESKANDARANY, MOHAMMED A., AGARWAL, DEVIKA, ELSHEIKH, SOMAIA, NOLAN, CHRISTOPHER C., DIEZ-RODRIGUEZ, MARIA, MACMILLAN, R. DOUGLAS, BALL, GRAHAM R., CALDAS, CARLOS, MADHUSUDAN, SRINIVASAN, ELLIS, IAN O. and RAKHA, EMAD A., 2016. MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours BRITISH JOURNAL OF CANCER. 114(8), 917-928 RAKHA, EMAD A., BADVE, SUNIL, EUSEBI, VINCENZO, REIS-FILHO, JORGE S., FOX, STEPHEN B., DABBS, DAVID J., DECKER, THOMAS, HODI, ZSOLT, ICHIHARA, SHU, LEE, ANDREW H. S., PALACIOS, JOSE, RICHARDSON, ANDREA L., VINCENT-SALOMON, ANNE, SCHMITT, FERNANDO C., PUAY-HOON TAN, TSE, GARY M. and ELLIS, IAN O., 2016. Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management HISTOPATHOLOGY. 68(1), 45-56 PAPANASTASIOU, ANASTASIOS D., WEN, HUEI CHI, SCHULTHEIS, ANNE M., NG, CHARLOTTE K. Y., EDELWEISS, MARCIA, PISCUOGLIO, SALVATORE, MARTELOTTO, LUCIANO G., GEYER, FELIPE C., BURKE, KATHLEEN, DE FILIPPO, MARIA ROSARIA, MACEDO, GABRIEL S., VARGA, ZSUZSANNA, RAKHA, EMAD, ELLIS, IAN O., RUBIN, BRIAN P., WEIGELT, BRITTA and REIS-FILHO, JORGE S., 2016. The Mutational Landscape of Breast Adenomyoepitheliomas MODERN PATHOLOGY. 29, 64A-64A
OGDEN, ANGELA, GREEN, ANDREW, ALESKANDARANY, MOHAMMED A., RAKHA, EMAD, ELLIS, IAN O., ALI, SIMAK, LI, XIAOXIAN, KRISHNAMURTI, UMA, REID, MICHELLE D., RIDA, PADMASHREE C. G. and ANEJA, RITU, 2016. Retinoic Acid Receptor Alpha Is a Positive Prognostic Biomarker in Triple-Negative Breast Cancer LABORATORY INVESTIGATION. 96, 62A-63A
GREEN, ANDREW R, SORIA, DANIELE, STEPHEN, JACQUELINE, POWE, DESMOND G, NOLAN, CHRISTOPHER C, KUNKLER, IAN, THOMAS, JEREMY, KERR, GILLIAN R, JACK, WILMA, CAMERON, DAVID, PIPER, TAMMY, BALL, GRAHAM R, GARIBALDI, JONATHAN M, RAKHA, EMAD A, BARTLETT, JOHN MS and ELLIS, IAN O, 2016. Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series. The journal of pathology. Clinical research. 2(1), 32-40 NEGM, OLA H., MUFTAH, ABIR A., ALESKANDARANY, MOHAMMED A., HAMED, MOHAMED R., AHMAD, DENA A. J., NOLAN, CHRISTOPHER C., DIEZ-RODRIGUEZ, MARIA, TIGHE, PATRICK J., ELLIS, IAN O., RAKHA, EMAD A. and GREEN, ANDREW R., 2016. Clinical utility of reverse phase protein array for molecular classification of breast cancer BREAST CANCER RESEARCH AND TREATMENT. 155(1), 25-35 RAKHA, EMAD A., ABBAS, AREEG and SHEERAN, RACHAEL, 2016. Invasive Lobular Carcinoma Mimicking Papillary Carcinoma: A Report of Three Cases PATHOBIOLOGY. 83(5), 221-227 RAKHA, E. A., 2016. Multigene Prognostic Assays in Breast Cancer - An Update JOURNAL OF PATHOLOGY. 238, S4-S4
OGDEN, ANGELA, GREEN, ANDREW, ALESKANDARANY, MOHAMMED A., RAKHA, EMAD, ELLIS, IAN O., LI, XIAOXIAN, KRISHNAMURTI, UMA, REID, MICHELLE D., RIDA, PADMASHREE C. G. and ANEJA, RITU, 2016. High HER3-EGFR Score Predicts Aggressive Disease Course in Triple-Negative Breast Cancer MODERN PATHOLOGY. 29, 63A-63A
BELLERBY, REBECCA, SMITH, CHRIS, KYME, SUE, GEE, JULIA, GUNTHERT, URSULA, GREEN, ANDY, RAKHA, EMAD, BARRETT-LEE, PETER and HISCOX, STEPHEN, 2016. Overexpression of specific cD44 isoforms is associated with aggressive cell Features in acquired endocrine resistance FRONTIERS IN ONCOLOGY. 6, GREEN, ANDREW R., SORIA, D., POWE, D. G., NOLAN, C. C., ALESKANDARANY, M., SZASZ, M. A., TOKES, A. M., BALL, G. R., GARIBALDI, J. M., RAKHA, E. A., KULKA, J. and ELLIS, I. O., 2016. Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer (vol 157, pg 65, 2016) BREAST CANCER RESEARCH AND TREATMENT. 159(1), TAN, BENJAMIN Y., ACS, GEZA, APPLE, SOPHIA K., BADVE, SUNIL, BLEIWEISS, IRA J., BROGI, EDI, CALVO, JOSE P., DABBS, DAVID J., ELLIS, IAN O., EUSEBI, VINCENZO, FARSHID, GELAREH, FOX, STEPHEN B., ICHIHARA, SHU, LAKHANI, SUNIL R., RAKHA, EMAD A., REIS-FILHO, JORGE S., RICHARDSON, ANDREA L., SAHIN, AYSEGUL, SCHMITT, FERNANDO C., SCHNITT, STUART J., SIZIOPIKOU, KALLIOPI P., SOARES, FERNANDO A., TSE, GARY M., VINCENT-SALOMON, ANNE and PUAY HOON TAN, 2016. Phyllodes tumours of the breast: a consensus review HISTOPATHOLOGY. 68(1), 5-21 CRAZE, M., JOSEPH, C., SORIA, D., NOLAN, C., GREEN, A., RAKHA, E., ELLIS, I. O. and MUKHERJEE, A., 2016. Molecular Pathology of Low Grade Oestrogen Receptor Positive Breast Cancer: Cues from Immunohistochemistry and Informatics JOURNAL OF PATHOLOGY. 238, S6-S6
EBERLE, CAREY A., PISCUOGLIO, SALVATORE, RAKHA, EMAD A., NG, CHARLOTTE K. Y., GEYER, FELIPE C., EDELWEISS, MARCIA, SAKR, RITA A., WEIGELT, BRITTA, REIS-FILHO, JORGE S. and ELLIS, IAN O., 2016. Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile HISTOPATHOLOGY. 68(7), 1030-1039 LANGLANDS, FIONA, CORNFORD, ELEANOR, RAKHA, EMAD, DALL, BARBARA, GUTTERIDGE, ELEANOR, DODWELL, DAVID, SHAABAN, ABEER M. and SHARMA, NISHA, 2016. Imaging overview of metaplastic carcinomas of the breast: a large study of 71 cases BRITISH JOURNAL OF RADIOLOGY. 89(1064), RAKHA EA, AGARWAL D, GREEN AR, ASHANKYTY I, ELLIS IO, BALL G and ALASKANDARANY MA, 2016. Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer. Histopathology. (In Press.)
MILIGY, I., GABER, A., MOHAN, P., NOLAN, C., DIEZ-RODRIGUEZ, M., CRAZE, M., JOSEPH, C., AL-KAABI, M. M., ALESKANDARANY, M. A., MUKHERJEE, A., CHAPMAN, C., MACMILLAN, R. D., ELLIS, I. O., GREEN, A. R. and RAKHA, E. A., 2016. Prognostic Significance of Tumour Infiltrating Lymphocytes in Ductal Carcinoma In Situ JOURNAL OF PATHOLOGY. 240, 26-26
ABDULJABBAR R, AL-KAABI MM, NEGM OH, JERJEES D, MUFTAH AA, MUKHERJEE A, LAI CF, BULUWELA L, ALI S, TIGHE PJ, GREEN A, ELLIS I and RAKHA E, 2015. Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer. Breast cancer research and treatment. 150(3), 511-22 REA D, FRANCIS A, HANBY AM, SPEIRS V, RAKHA E, SHAABAN A, CHAN S, VINNICOMBE S, ELLIS IO, MARTIN SG, JONES LJ and BERDITCHEVSKI F, 2015. Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research. British journal of cancer. (In Press.)
ABDULJABBAR R, NEGM OH, LAI C, JERJEES DA, AL-KAABI M, HAMED MR, TIGHE PJ, BULUWELA L, MUKHERJEE A, GREEN AR, ALI S, RAKHA EA and ELLIS IO, 2015. Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer. Breast cancer research and treatment. 150(2), 335-46 JERJEES DA, NEGM OH, ALABDULLAH ML, MIRZA S, ALKAABI M, HAMEED MR, ABDULJABBAR R, MUFTAH A, NOLAN CC, GREEN AR, TIGHE PJ, BAND V, ELLIS IO and RAKHA EA, 2015. The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways. Breast cancer research and treatment. 150(1), 91-103 ALESKANDARANY M, CARACAPPA D, NOLAN CC, MACMILLAN RD, ELLIS IO, RAKHA EA and GREEN AR, 2015. DNA damage response markers are differentially expressed in BRCA-mutated breast cancers. Breast cancer research and treatment. 150(1), 81-90 AL-KAABI MM, ALSHAREEDA AT, JERJEES DA, MUFTAH AA, GREEN AR, ALSUBHI NH, NOLAN CC, CHAN S, CORNFORD E, MADHUSUDAN S, ELLIS IO and RAKHA EA, 2015. Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response. British journal of cancer. 112(5), 901-11 PISCUOGLIO S, HODI Z, KATABI N, GUERINI-ROCCO E, MACEDO GS, NG CKY, EDELWEISS M, DE MATTOS-ARRUDA L, WEN HY, RAKHA EA, ELLIS IO, RUBIN BP, WEIGELT B and REIS-FILHO JS, 2015. Are acinic cell carcinomas of the breast and salivary glands distinct diseases? Histopathology. (In Press.)
ARORA A, ABDEL-FATAH TMA, AGARWAL D, DOHERTY R, MOSELEY PM, ALESKANDARANY MA, GREEN AR, BALL G, ALSHAREEDA AT, RAKHA EA, CHAN SYT, ELLIS IO and MADHUSUDAN S, 2015. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer. Molecular cancer therapeutics. 14(4), 1057-65 GALE K, RAKHA E, BALL G, TAN V, MCCULLEY S and MACMILLAN R, 2015. A case controlled study of the oncological safety of fat grafting. Plastic and reconstructive surgery. (In Press.)
LEE AHS, RAKHA EA and ELLIS IO, 2015. Brief fixation and hormone receptor expression in breast cancer. The American journal of surgical pathology. 39(3), 425 GREEN AR, CARACAPPA D, BENHASOUNA AA, ALSHAREEDA A, NOLAN CC, MACMILLAN RD, MADHUSUDAN S, ELLIS IO and RAKHA EA, 2015. Biological and clinical significance of PARP1 protein expression in breast cancer. Breast cancer research and treatment. 149(2), 353-62 RAKHA EA, PINDER SE, BARTLETT JMS, IBRAHIM M, STARCZYNSKI J, CARDER PJ, PROVENZANO E, HANBY A, HALES S, LEE AHS, ELLIS IO and NATIONAL COORDINATING COMMITTEE FOR BREAST PATHOLOGY, 2015. Updated UK Recommendations for HER2 assessment in breast cancer. Journal of clinical pathology. 68(2), 93-9 ABDEL-FATAH TMA, MIDDLETON FK, ARORA A, AGARWAL D, CHEN T, MOSELEY PM, PERRY C, DOHERTY R, CHAN S, GREEN AR, RAKHA E, BALL G, ELLIS IO, CURTIN NJ and MADHUSUDAN S, 2015. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer. Molecular oncology. 9(3), 569-85 RAKHA EA, TAN PH, VARGA Z, TSE GM, SHAABAN AM, CLIMENT F, VAN DEURZEN CHM, PURNELL D, DODWELL D, CHAN T and ELLIS IO, 2015. Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study. British journal of cancer. 112(2), 283-9 NELSON, LAURA, MCKEEN, HAYLEY D., MARSHALL, ANDREA, MULRANE, LAOIGHSE, STARCZYNSKI, JANE, STORR, SARAH J., LANIGAN, FIONA, BYRNE, CHRISTOPHER, ARTHUR, KEN, HEGARTY, SHAUNA, ALI, AHLAM ABDUNNABI, FURLONG, FIONA, MCCARTHY, HELEN O., ELLIS, IAN O., GREEN, ANDREW R., RAKHA, EMAD, YOUNG, LEONIE, KUNKLER, IAN, THOMAS, JEREMY, JACK, WILMA, CAMERON, DAVID, JIRSTROM, KARIN, YAKKUNDI, ANITA, MCCLEMENTS, LANA, MARTIN, STEWART G., GALLAGHER, WILLIAM M., DUNN, JANET, BARTLETT, JOHN, O'CONNOR, DARRAN and ROBSON, TRACY, 2015. FKBPL: a marker of good prognosis in breast cancer ONCOTARGET. 6(14), 12209-12223 ABDULJABBAR, REZVAN, NEGM, OLA H., LAI, CHUN-FUI, JERJEES, DENA A., AL-KAABI, METHAQ, HAMED, MOHAMED R., TIGHE, PATRICK J., BULUWELA, LAKJAYA, MUKHERJEE, ABHIK, GREEN, ANDREW R., ALI, SIMAK, RAKHA, EMAD A. and ELLIS, IAN O., 2015. Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer BREAST CANCER RESEARCH AND TREATMENT. 150(2), 335-346 MAGNANI, LUCA, PATTEN, DARREN K., NGUYEN, VAN T. M., HONG, SUNG-PIL, STEEL, JENNIFER H., PATEL, NAINA, LOMBARDO, YLENIA, FARONATO, MONICA, GOMES, ANA R., WOODLEY, LAURA, PAGE, KAREN, GUTTERY, DAVID, PRIMROSE, LINDSAY, GARCIA, DANIEL FERNANDEZ, SHAW, JACQUI, VIOLA, PATRIZIA, GREEN, ANDREW, NOLAN, CHRISTOPHER, ELLIS, IAN O., RAKHA, EMAD A., SHOUSHA, SAMI, LAM, ERIC W. -F., GYORFFY, BALAZS, LUPIEN, MATHIEU and COOMBES, R. CHARLES, 2015. The pioneer factor PBX1 is a novel driver of metastatic progression in ER'-positive breast cancer ONCOTARGET. 6(26), 21878-21891 ALESKANDARANY, MOHAMMED A., SORIA, D., GREEN, A. R., NOLAN, C., DIEZ-RODRIGUEZ, MARIA, ELLIS, I. O. and RAKHA, E. A., 2015. Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification BREAST CANCER RESEARCH AND TREATMENT. 151(2), 325-333 GUERINI-ROCCO, ELENA, HODI, ZSOLT, PISCUOGLIO, SALVATORE, NG, CHARLOTTE K. Y., RAKHA, EMAD A., SCHULTHEIS, ANNE M., MARCHIO, CATERINA, PAULA, ARNAUD DA CRUZ, DE FILIPPO, MARIA R., MARTELOTTO, LUCIANO G., DE MATTOS-ARRUDA, LETICIA, EDELWEISS, MARCIA, JUNGBLUTH, ACHIM A., FUSCO, NICOLA, NORTON, LARRY, WEIGELT, BRITTA, ELLIS, IAN O. and REIS-FILHO, JORGE S., 2015. The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study JOURNAL OF PATHOLOGY. 237(2), 166-178 ALESKANDARANY, MOHAMMED A., SONBUL, SULTAN N., MUKHERJEE, ABHIK and RAKHA, EMAD A., 2015. Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer PATHOBIOLOGY. 82(3-4), 113-123 PINDER, SARAH E., RAKHA, EMAD A., PURDIE, COLIN A., BARTLETT, JOHN M. S., FRANCIS, ADELE, STEIN, ROBERT C., THOMPSON, ALASTAIR M. and SHAABAN, ABEER M., 2015. Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches HISTOPATHOLOGY. 67(3), 279-293 ALESKANDARANY, M. A., NEGM, O. H., TIGHE, P., NOLAN, C., GREEN, A. R., RAKHA, E. A. and ELLIS, I. O., 2015. The Prognostic Significance of STAT3 Expression in Invasive Breast Cancer: an Immunohistochemical and Reverse Phase Protein Array Study JOURNAL OF PATHOLOGY. 237, S32-S32
ALESKANDARANY, M. A., GREEN, A. R., SAMAKA, R. M., MACMILLAN, R. D., CARACAPPA, D., ELLIS, I. O., DIEZ-RODRIGUEZ, M., RAKHA, E. A., NOLAN, C. and AL-KABBI, M. M., 2015. Cadherin Switch is More Observed in BRCA1 Mutated than the Basal-Like Breast Cancers JOURNAL OF PATHOLOGY. 237, S18-S18
RAKHA, EMAD, PAJARES, MARIA J., ILIE, MARIUS, PIO, RUBEN, ECHEVESTE, JOSE, HUGHES, ELISHA, SOOMRO, IRSHAD, LONG, ELODIE, IDOATE, MIGUEL A., WAGNER, SUSANNE, LANCHBURY, JERRY S., BALDWIN, DAVID R., HOFMAN, PAUL and MONTUENGA, LUIS M., 2015. Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators EUROPEAN JOURNAL OF CANCER. 51(14), 1897-1903 ALSHAREEDA AT, NEGM OH, GREEN AR, NOLAN C, TIGHE P, ALBARAKATI N, SULTANA R, MADHUSUDAN S, ELLIS IO and RAKHA EA, 2014. SUMOylation proteins in breast cancer. Breast cancer research and treatment. 144(3), 519-30 ALBARAKATI N, ABDEL-FATAH TMA, DOHERTY R, RUSSELL R, AGARWAL D, MOSELEY P, PERRY C, ARORA A, ALSUBHI N, SEEDHOUSE C, RAKHA EA, GREEN A, BALL G, CHAN S, CALDAS C, ELLIS IO and MADHUSUDAN S, 2014. Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy. Molecular oncology. 9(1), 204-17 ABDEL-FATAH T, ARORA A, AGARWAL D, MOSELEY P, PERRY C, THOMPSON N, GREEN AR, RAKHA E, CHAN S, BALL G, ELLIS IO and MADHUSUDAN S, 2014. Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers. Breast cancer research and treatment. 146(2), 309-20 ALESKANDARANY MA, NEGM OH, GREEN AR, AHMED MAH, NOLAN CC, TIGHE PJ, ELLIS IO and RAKHA EA, 2014. Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study. Breast cancer research and treatment. 145(2), 339-48 ABDEL-FATAH TMA, ARORA A, ALSUBHI N, AGARWAL D, MOSELEY PM, PERRY C, DOHERTY R, CHAN SYT, GREEN AR, RAKHA E, BALL G, ELLIS IO and MADHUSUDAN S, 2014. Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts. Neoplasia (New York, N.Y.). 16(11), 982-91 JERJEES DA, ALABDULLAH M, ALKAABI M, ABDULJABBAR R, MUFTAH A, NOLAN C, GREEN AR, ELLIS IO and RAKHA EA, 2014. ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer. Breast cancer research and treatment. 147(1), 25-37 ALI HR, PROVENZANO E, DAWSON S, BLOWS FM, LIU B, SHAH M, EARL HM, POOLE CJ, HILLER L, DUNN JA, BOWDEN SJ, TWELVES C, BARTLETT JMS, MAHMOUD SMA, RAKHA E, ELLIS IO, LIU S, GAO D, NIELSEN TO, PHAROAH PDP and CALDAS C, 2014. Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 25(8), 1536-43 AGBOOLA AOJ, BANJO AAF, ANUNOBI CC, AYOADE BA, DEJI-AGBOOLA AM, MUSA AA, ABDEL-FATAH T, NOLAN CC, RAKHA EA, ELLIS IO and GREEN AR, 2014. Molecular profiling of breast cancer in Nigerian women identifies an altered p53 pathway as a major mechanism underlying its poor prognosis compared with British counterpart. The Malaysian journal of pathology. 36(1), 3-17
JERJEES DA, ALABDULLAH M, GREEN AR, ALSHAREEDA A, MACMILLAN RD, ELLIS IO and RAKHA EA, 2014. Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer. Breast cancer research and treatment. 145(2), 317-30 GREEN AR, BARROS FFT, ABDEL-FATAH TMA, MOSELEY P, NOLAN CC, DURHAM AC, RAKHA EA, CHAN S and ELLIS IO, 2014. HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer. Breast cancer research and treatment. 145(1), 33-44 BARROS FFT, ABDEL-FATAH TMA, MOSELEY P, NOLAN CC, DURHAM AC, RAKHA EA, CHAN S, ELLIS IO and GREEN AR, 2014. Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay. Breast cancer research and treatment. 144(2), 273-85 RAKHA EA and ELLIS IO, 2014. Breast cancer: updated guideline recommendations for HER2 testing. Nature reviews. Clinical oncology. 11(1), 8-9 AGBOOLA AOJ, MUSA AA, AYOADE BA, BANJO AA, ANUNOBI CC, DEJI-AGBOOLA AM, RAKHA EA, NOLAN C, ELLIS IO and GREEN AR, 2014. Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women. Pathology, research and practice. 210(1), 10-7 AGBOOLA A, MUSA A, BANJO A, AYOADE B, DEJI-AGBOOLA M, NOLAN C, RAKHA E, ELLIS I and GREEN A, 2014. PIASγ expression in relation to clinicopathological, tumour factors and survival in indigenous black breast cancer women. Journal of clinical pathology. 67(4), 301-6 HO-YEN CM, GREEN AR, RAKHA EA, BRENTNALL AR, ELLIS IO, KERMORGANT S and JONES JL, 2014. C-Met in invasive breast cancer: is there a relationship with the basal-like subtype? Cancer. 120(2), 163-71 JERJEES, D., NEJM, O., MIRZA, S., ABDULJABBAR, R., GREEN, A., TIGHE, P., BAND, V., ELLIS, I. and RAKHA, E., 2014. The biological and clinical significance of phosphorylated mTOR (pi3k/AKt pathway related) and its association with estrogen receptor and HER2 pathways VIRCHOWS ARCHIV. 465, S99-S99
ALESKANDARANY, MOHAMMED A., NEGM, OLA H., GREEN, ANDREW R., AHMED, MOHAMED A. H., NOLAN, CHRISTOPHER C., TIGHE, PATRICK J., ELLIS, IAN O. and RAKHA, EMAD A., 2014. Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study BREAST CANCER RESEARCH AND TREATMENT. 145(2), 339-348 JERJEES, D., NEJM, O., MIRZA, S., ABDULJABBAR, R., ALSUBHI, N., NOLAN, C., GREEN, A., TIGHE, P., BAND, V., ELLIS, I. and RAKHA, E., 2014. ERK1/2 expression in breast cancer: The impact of subcellular localisation VIRCHOWS ARCHIV. 465, S107-S107
AL-KAABI, M., ALASHAREEDA, A., JERJEES, D., MUFTAH, A. A. ABDELHADI, ALSUBHI, N., GREEN, A., CHAN, S., CORNFORD, E., MADHUSUDAN, S., ELLIS, I. and RAKHA, E., 2014. Checkpoint Kinase1 (CHK1) is an important biomarker in breast cancer related to DNA-damage repair mechanism and response to chemotherapy VIRCHOWS ARCHIV. 465, S104-S104
MUFTAH, A. A. ABDELHADI, AL-KAABI, M., ALESKANDARANY, M., JERJEES, D., ALSOBHI, N., ABDULJABBAR, R., NOLAN, C., GREEN, A., ELLIS, I. and RAKHA, E., 2014. The proliferation marker Ki67 in breast cancer: A reliability study to assess its readiness for routine clinical management VIRCHOWS ARCHIV. 465, S104-S104
RAKHA, E., 2014. Selection of patients for OncotypeDx testing in breast cancer in the UK VIRCHOWS ARCHIV. 465, S115-S115
HO-YEN, COLAN M., GREEN, ANDREW R., RAKHA, EMAD A., BRENTNALL, ADAM R., ELLIS, IAN O., KERMORGANT, STEPHANIE and JONES, J. L., 2014. C-Met in Invasive Breast Cancer CANCER. 120(2), 163-171 SULTANA, R., ABDEL-FATAH, T., ABBOTTS, R., HAWKES, C., ALBARAKATI, N., SEEDHOUSE, C., BALL, G., CHAN, S., RAKHA, E.A., ELLIS, I.O. and MADHUSUDAN, S., 2013. Targeting XRCC1 deficiency in breast cancer for personalized therapy Cancer Research. 73(5), 1621-1634 KHOSHNAW SM, RAKHA EA, ABDEL-FATAH T, NOLAN CC, HODI Z, MACMILLAN RD, ELLIS IO and GREEN AR, 2013. The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients. Breast cancer research and treatment. 137(1), 139-53 BAKER BG, BALL GR, RAKHA EA, NOLAN CC, CALDAS C, ELLIS IO and GREEN AR, 2013. Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer. Breast cancer research and treatment. 137(1), 127-37 RAKHA EA, TAN PH, SHAABAN A, TSE GM, ESTELLER FC, VAN DEURZEN CHM, PURNELL D, STOTTER A, CHAN T, YAMAGUCHI R, DODWELL D, JAGER A, SOLER MT, JUNEINAH E, PLAZA ML, HODI Z, MCCULLOCH T, LEE AHS and ELLIS IO, 2013. Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumours. Breast (Edinburgh, Scotland). 22(1), 13-8 RAKHA EA, SHAABAN AM, HAIDER SA, JENKINS J, MENON S, JOHNSON C, YAMAGUCHI R, MURPHY A, LISTON J, CORNFORD E, HAMILTON L, JAMES J, ELLIS IO and LEE AHS, 2013. Outcome of pure mucocele-like lesions diagnosed on breast core biopsy. Histopathology. (In Press.)
MIRZA S, RAKHA EA, ALSHAREEDA A, MOHIBI S, ZHAO X, KATAFIASZ BJ, WANG J, GURUMURTHY CB, BELE A, ELLIS IO, GREEN AR, BAND H and BAND V, 2013. Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients. Breast cancer research and treatment. 137(3), 721-31 BROUCKAERT O, PARIDAENS R, FLORIS G, RAKHA E, OSBORNE K and NEVEN P, 2013. A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 24(1), 47-53 ECCLES SA, ABOAGYE EO, ALI S, ANDERSON AS, ARMES J, BERDITCHEVSKI F, BLAYDES JP, BRENNAN K, BROWN NJ, BRYANT HE, BUNDRED NJ, BURCHELL JM, CAMPBELL AM, CARROLL JS, CLARKE RB, COLES CE, COOK GJR, COX A, CURTIN NJ, DEKKER LV, SILVA IDS, DUFFY SW, EASTON DF, ECCLES DM, EDWARDS DR, EDWARDS J, EVANS D, FENLON DF, FLANAGAN JM, FOSTER C, GALLAGHER WM, GARCIA-CLOSAS M, GEE JMW, GESCHER AJ, GOH V, GROVES AM, HARVEY AJ, HARVIE M, HENNESSY BT, HISCOX S, HOLEN I, HOWELL SJ, HOWELL A, HUBBARD G, HULBERT-WILLIAMS N, HUNTER MS, JASANI B, JONES LJ, KEY TJ, KIRWAN CC, KONG A, KUNKLER IH, LANGDON SP, LEACH MO, MANN DJ, MARSHALL JF, MARTIN L, MARTIN SG, MACDOUGALL JE, MILES DW, MILLER WR, MORRIS JR, MOSS SM, MULLAN P, NATRAJAN R, O'CONNOR JPB, O'CONNOR R, PALMIERI C, PHAROAH PDP, RAKHA EA, REED E, ROBINSON SP, SAHAI E, SAXTON JM, SCHMID P, SMALLEY MJ, SPEIRS V, STEIN R, STINGL J, STREULI CH, TUTT ANJ, VELIKOVA G, WALKER RA, WATSON CJ, WILLIAMS KJ, YOUNG LS and THOMPSON AM, 2013. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast cancer research : BCR. 15(5), R92 1-37 DABBS DJ, SCHNITT SJ, GEYER FC, WEIGELT B, BAEHNER FL, DECKER T, EUSEBI V, FOX SB, ICHIHARA S, LAKHANI SR, PALACIOS J, RAKHA E, RICHARDSON AL, SCHMITT FC, TAN P, TSE GM, VINCENT-SALOMON A, ELLIS IO, BADVE S and REIS-FILHO JS, 2013. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. The American journal of surgical pathology. 37(7), e1-11 RAKHA EA, O'TOOLE SA, ELLIS IO and TAN PH, 2013. Breast pathology today: morphology and molecules. Journal of clinical pathology. 66(6), 457 AGBOOLA AOJ, BANJO AAF, ANUNOBI CC, SALAMI B, AGBOOLA MD, MUSA AA, NOLAN CC, RAKHA EA, ELLIS IO and GREEN AR, 2013. Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women. ISRN oncology. 2013, 675051 AGBOOLA AJ, MUSA AA, WANANGWA N, ABDEL-FATAH T, NOLAN CC, AYOADE BA, OYEBADEJO TY, BANJO AA, DEJI-AGBOOLA AM, RAKHA EA, GREEN AR and ELLIS IO, 2013. Too many statistical errors for meaningful interpretation. Response to letter to the editor. Breast cancer research and treatment. 138(2), 645-50
ALSHAREEDA AT, NEGM OH, ALBARAKATI N, GREEN AR, NOLAN C, SULTANA R, MADHUSUDAN S, BENHASOUNA A, TIGHE P, ELLIS IO and RAKHA EA, 2013. Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer. Breast cancer research and treatment. 139(2), 301-10 RAKHA EA, 2013. Pitfalls in outcome prediction of breast cancer. Journal of clinical pathology. 66(6), 458-64 BAKER, B. G., BALL, G. R., RAKHA, E. A., NOLAN, C. C., CALDAS, C., ELLIS, I. O. and GREEN, A. R., 2013. Lack of expression of the proteins GMPR2 and PPAR alpha are associated with the basal phenotype and patient outcome in breast cancer BREAST CANCER RESEARCH AND TREATMENT. 137(1), 127-137 ALESKANDARANY, M. A., NEGM, O. H., RAKHA, E. A., AHMED, M. A. H., NOLAN, C. C., TIGHE, P. J., GREEN, A. R. and ELLIS, I. O., 2013. Epithelial Mesenchymal Transition in Early Invasive Breast Cancer: Further Evidence Using Reverse Phase Protein Array JOURNAL OF PATHOLOGY. 231, 19-19
KHOSHNAW, S. M., REIS-FILHO, J. S., LAMBROS, M. B., BALL, G., RAKHA, E. A., ABDEL-FATAH, T. M., NOLAN, C. C., HODI, Z., MACMILLAN, D. R., ELLIS, I. O. and GREEN, A. R., 2013. High-Throughput Assessment of MicroRNA Expression in Normal Breast Tissues and in Lesions Representing Different Stages of Breast Cancer Progression JOURNAL OF PATHOLOGY. 231, 13-13
JERJEES, D. A., ABDULJABBAR, R. F., GREEN, A. R., ELLIS, I. O. and RAKHA, E. A., 2013. The Biological and Clinical Significance of p-JNK1/2 in Human Breast Cancer JOURNAL OF PATHOLOGY. 231, 20-20
ZHAO X, MIRZA S, ALSHAREEDA A, ZHANG Y, GURUMURTHY CB, BELE A, KIM JH, MOHIBI S, GOSWAMI M, LELE SM, WEST W, QIU F, ELLIS IO, RAKHA EA, GREEN AR, BAND H and BAND V, 2012. Overexpression Of A Novel Cell Cycle Regulator Ecdysoneless In Breast Cancer: A Marker Of Poor Prognosis In Her2/Neu-Overexpressing Breast Cancer Patients. Breast Cancer Research And Treatment. (In Press.)
ALESKANDARANY MA, GREEN AR, BENHASOUNA AA, BARROS FF, NEAL KR, REIS-FILHO JS, ELLIS IO and RAKHA EA, 2012. Prognostic Value Of Proliferation Assay In The Luminal, Her2 Positive And Triple Negative Biological Classes Of Breast Cancer. Breast Cancer Research : Bcr. 14(1), R3 (In Press.)
RAKHA, E.A., MARTIN, S., LEE, A.H.S., MORGAN, D., PHAROAH, P.D.P., HODI, Z., MACMILLAN, D. and ELLIS, I.O., 2012. The prognostic significance of lymphovascular invasion in invasive breast carcinoma Cancer. 118(15), 3670-3680 MUKHERJEE A and RAKHA EA, 2012. Integrating Breast Cancer Genetics Into Clinical Practice. Women's Health (London, England). 8(1), 99-112 ALESKANDARANY, M. A., NEGM, O. H., RAKHA, E. A., AHMED, M. A., NOLAN, C. C., BALL, G. R., CALDAS, C., GREEN, A. R., TIGHE, P. J. and ELLIS, I. O., 2012. TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome Breast cancer research and treatment. 136(2), 419-27 AGBOOLA AJ, MUSA AA, WANANGWA N, ABDEL-FATAH T, NOLAN CC, AYOADE BA, OYEBADEJO TY, BANJO AA, DEJI-AGBOOLA AM, RAKHA EA, GREEN AR and ELLIS IO, 2012. Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women. Breast cancer research and treatment. 135(2), 555-69 KHOSHNAW SM, RAKHA EA, ABDEL-FATAH TM, NOLAN CC, HODI Z, MACMILLAN DR, ELLIS IO and GREEN AR, 2012. Loss of Dicer expression is associated with breast cancer progression and recurrence. Breast cancer research and treatment. 135(2), 403-13 RAKHA EA, LEE AHS, ROBERTS J, VILLENA SALINAS NM, HODI Z, ELLIS IO and REIS-FILHO JS, 2012. Low-estrogen receptor-positive breast cancer: the impact of tissue sampling, choice of antibody, and molecular subtyping. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(23), 2929-30; author reply 2931 ALSHAREEDA AT, RAKHA EA, NOLAN CC, ELLIS IO and GREEN AR, 2012. Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer. Breast cancer research and treatment. 134(2), 519-29 RAKHA EA, TUN M, JUNAINAH E, ELLIS IO and GREEN A, 2012. Encapsulated papillary carcinoma of the breast: a study of invasion associated markers. Journal of clinical pathology. 65(8), 710-4 YAMAGUCHI R, MAESHIRO K, ELLIS IO, RAKHA EA, TAGUCHI J, SHIMA I, KAMEI H, SUZUKI M, IMAMURA M, NAKAYAMA G and YANO H, 2012. Infiltrative epitheliosis of the breast. Journal of clinical pathology. 65(8), 766-8 RAKHA E, WONG SC, SOOMRO I, CHAUDRY Z, SHARMA A, DEEN S, CHAN S, ABU J, NUNNS D, WILLIAMSON K, MCGREGOR A, HAMMOND R and BROWN L, 2012. Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature. The American journal of surgical pathology. 36(11), 1683-90 WISHART GC, BAJDIK CD, DICKS E, PROVENZANO E, SCHMIDT MK, SHERMAN M, GREENBERG DC, GREEN AR, GELMON KA, KOSMA V, OLSON JE, BECKMANN MW, WINQVIST R, CROSS SS, SEVERI G, HUNTSMAN D, PYLKÄS K, ELLIS I, NIELSEN TO, GILES G, BLOMQVIST C, FASCHING PA, COUCH FJ, RAKHA E, FOULKES WD, BLOWS FM, BÉGIN LR, VAN'T VEER LJ, SOUTHEY M, NEVANLINNA H, MANNERMAA A, COX A, CHEANG M, BAGLIETTO L, CALDAS C, GARCIA-CLOSAS M and PHAROAH PDP, 2012. PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. British journal of cancer. 107(5), 800-7 RAKHA EA, CLARK D, CHOHAN BS, EL-SAYED M, SEN S, BAKOWSKI L and O'CONNOR S, 2012. Efficacy of an incident-reporting system in cellular pathology: a practical experience. Journal of clinical pathology. 65(7), 643-8 ALESKANDARANY MA, NEGM OH, RAKHA EA, AHMED MAH, NOLAN CC, BALL GR, CALDAS C, GREEN AR, TIGHE PJ and ELLIS IO, 2012. TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome. Breast cancer research and treatment. 136(2), 419-27 GREEN, ANDREW R, ELLIS, IAN O, KHOSHNAW, SARKAWT M, ABDEL-FATAH, TAREK M, RAKHA, EMAD A, NOLAN, CHRISTOPHER C, MACMILLAN, R D, REIS-FILHO, JORGE S, LAMBROS, MARYOU B, BALL, GRAHAM R and HODI, ZSOLT, 2012. MicroRNAs expression profiling during breast cancer progression ArrayExpress Archive.
KHOSHNAW, SARKAWT M, REIS-FILHO, JORGE S, LAMBROS, MARYOU B, BALL, GRAHAM R, RAKHA, EMAD A, ABDEL-FATAH, TAREK M, NOLAN, CHRISTOPHER C, HODI, ZSOLT, MACMILLAN, R D, ELLIS, IAN O and GREEN, ANDREW R, 2012. GSM951057: Case four: ductal carcinoma in situ Gene Expression Omnibus.
HABASHY, HANY O., POWE, DESMOND G., ABDEL-FATAH, TAREK M., GEE, JULIA M. W., NICHOLSON, ROBERT I., GREEN, ANDREW R., RAKHA, EMAD A. and ELLIS, IAN O., 2012. A review of the biological and clinical characteristics of luminal-like oestrogen receptor-positive breast cancer HISTOPATHOLOGY. 60(6), 854-863 RAKHA, E. A., ROBERTS, J., AHMED, Z., ELLIS, I. O., LEE, A. H. and GREEN, A., 2012. Oestrogen Receptor Negative Progesterone Receptor Positive Phenotype in Breast Cancer is a Technical Artefact. JOURNAL OF PATHOLOGY. 228, S22-S22
AHMED, MOHAMED A. H., ALESKANDARANY, MOHAMMED A., RAKHA, EMAD A., MOUSTAFA, RADWA Z. A., BENHASOUNA, AHMED, NOLAN, CHRISTOPHER, GREEN, ANDREW R., ILYAS, MOHAMMAD and ELLIS, IAN O., 2012. A CD44(-)/CD24(+) phenotype is a poor prognostic marker in early invasive breast cancer BREAST CANCER RESEARCH AND TREATMENT. 133(3), 979-995 RAKHA, E. A., VAN DEURZEN, C. M. H., MACMILLAN, R. D., ELLIS, I. O. and LEE, A. H. S., 2012. Pleomorphic Lobular Carcinoma of the Breast: is it a Prognostically Significant Pathological Subtype Independent of Histological Grade? JOURNAL OF PATHOLOGY. 228, S11-S11
KHOSHNAW, SARKAWT M, REIS-FILHO, JORGE S, LAMBROS, MARYOU B, BALL, GRAHAM R, RAKHA, EMAD A, ABDEL-FATAH, TAREK M, NOLAN, CHRISTOPHER C, HODI, ZSOLT, MACMILLAN, R D, ELLIS, IAN O and GREEN, ANDREW R, 2012. GSM951066: Case six: invasive breast cancer tissue Gene Expression Omnibus.
JERJEES, D., GREEN, A., BENHASOUNA, A., ALSHAREEDA, A., ABDULJABBAR, R., BARROS, F., NOLAN, C., ELLIS, I. and RAKHA, E., 2012. Biological significance of proliferation and HER2 overexpression in luminal/oestrogen receptor-positive breast cancer VIRCHOWS ARCHIV. 461, S4-S5
AGBOOLA AJ, PAISH EC, RAKHA EA, POWE DG, MACMILLAN RD, ELLIS IO and GREEN AR, 2011. Epcam Expression Is An Indicator Of Recurrence In Basal-Like Breast Cancer. Breast Cancer Research And Treatment. (In Press.)
FERNÁNDEZ B, PAISH EC, GREEN AR, LEE AHS, MACMILLAN RD, ELLIS IO and RAKHA EA, 2011. Lymph-Node Metastases In Invasive Lobular Carcinoma Are Different From Those In Ductal Carcinoma Of The Breast. Journal Of Clinical Pathology. 64(11), 995-1000 HABASHY HO, RAKHA EA, ALESKANDARANY M, AHMED MA, GREEN AR, ELLIS IO and POWE DG, 2011. Foxo3a Nuclear Localisation Is Associated With Good Prognosis In Luminal-Like Breast Cancer. Breast Cancer Research And Treatment. 129(1), 11-21 RAKHA EA, GANDHI N, CLIMENT F, VAN DEURZEN CHM, HAIDER SA, DUNK L, LEE AHS, MACMILLAN D and ELLIS IO, 2011. Encapsulated Papillary Carcinoma Of The Breast: An Invasive Tumor With Excellent Prognosis. The American Journal Of Surgical Pathology. 35(8), 1093-103 VAN DEURZEN CHM, LEE AHS, GILL MS, MENKE-PLUIJMERS MBE, JAGER A, ELLIS IO and RAKHA EA, 2011. Metaplastic Breast Carcinoma: Tumour Histogenesis Or Dedifferentiation? The Journal Of Pathology. 224(4), 434-7 RAKHA EA and CHAN S, 2011. Metastatic Triple-Negative Breast Cancer. Clinical Oncology (Royal College Of Radiologists (Great Britain)). 23(9), 587-600 RAKHA, EMAD A., LEE, ANDREW H. S., JENKINS, JACQUIE A., MURPHY, ALISON E., HAMILTON, LISA J. and ELLIS, IAN O., 2011. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening INTERNATIONAL JOURNAL OF CANCER. 129(6), 1417-1424 MOHAMMED, RABAB A. A., ELLIS, IAN O., MAHMMOD, ALI M., HAWKES, E. CLAIRE, GREEN, ANDREW R., RAKHA, EMAD A. and MARTIN, STEWART G., 2011. Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance MODERN PATHOLOGY. 24(6), 774-785 BADVE, SUNIL, DABBS, DAVID J., SCHNITT, STUART J., BAEHNER, FREDERICK L., DECKER, THOMAS, EUSEBI, VINCENZO, FOX, STEPHEN B., ICHIHARA, SHU, JACQUEMIER, JOCELYNE, LAKHANI, SUNIL R., PALACIOS, JOSE, RAKHA, EMAD A., RICHARDSON, ANDREA L., SCHMITT, FERNANDO C., TAN, PUAY-HOON, TSE, GARY M., WEIGELT, BRITTA, ELLIS, IAN O. and REIS-FILHO, JORGE S., 2011. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists MODERN PATHOLOGY. 24(2), 157-167 HABASHY, HANY ONSY, POWE, DESMOND G, RAKHA, EMAD A, BALL, GRAHAM, MACMILLAN, R DOUGLAS, GREEN, ANDREW R and ELLIS, IAN O, 2010. The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. Breast cancer research and treatment. 120(3), 603-12 HABASHY, HANY ONSY, POWE, DESMOND G, GLAAB, ENRICO, BALL, GRAHAM, SPITERI, INMACULADA, KRASNOGOR, NATALIO, GARIBALDI, JONATHAN M, RAKHA, EMAD A, GREEN, ANDREW R, CALDAS, C and ELLIS, IAN O, 2010. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype. Breast cancer research and treatment. ALESKANDARANY, MOHAMMED A, GREEN, ANDREW R, RAKHA, EMAD A, MOHAMMED, RABAB A, ELSHEIKH, SOMAIA E, POWE, DESMOND G, PAISH, EMMA C, MACMILLAN, R DOUGLAS, CHAN, STEVE, AHMED, SAMREEN I and ELLIS, IAN O, 2010. Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer. International journal of cancer. Journal international du cancer. 126(7), 1761-9 ALESKANDARANY, MOHAMMED A, RAKHA, EMAD A, AHMED, MOHAMED A H, POWE, DESMOND G, PAISH, EMMA C, MACMILLAN, R DOUGLAS, ELLIS, IAN O and GREEN, ANDREW R, 2010. PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis. Breast cancer research and treatment. 122(1), 45-53 LANCASHIRE, L J, POWE, D G, REIS-FILHO, J S, RAKHA, E, LEMETRE, C, WEIGELT, B, ABDEL-FATAH, T M, GREEN, A R, MUKTA, R, BLAMEY, R, PAISH, E C, REES, R C, ELLIS, I O and BALL, G R, 2010. A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks. Breast cancer research and treatment. 120(1), 83-93 ZHANG, H, RAKHA, E A, BALL, G R, SPITERI, I, ALESKANDARANY, M, PAISH, E C, POWE, D G, MACMILLAN, R D, CALDAS, C, ELLIS, I O and GREEN, A R, 2010. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer. Breast cancer research and treatment. 121(1), 41-51 HABASHY, HANY ONSY, POWE, DESMOND G, STAKA, CINDY M, RAKHA, EMAD A, BALL, GRAHAM, GREEN, ANDREW R, ALESKANDARANY, MOHAMMED, PAISH, E CLAIRE, DOUGLAS MACMILLAN, R, NICHOLSON, ROBERT I, ELLIS, IAN O and GE, 2010. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast cancer research and treatment. 119(2), 283-93 SORIA, D., GARIBALDI, J.M., AMBROGI, F., GREEN, A.R., POWE, D., RAKHA, E., MACMILLAN, R.D., BLAMEY, R.W., BALL, G., LISBOA, P.J.G., ETCHELLS, T.A., BORACCHI, P., BIGANZOLI, E. and ELLIS, I.O., 2010. A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients Computers in Biology and Medicine. 40(3), 318-330 RAKHA, EMAD A, LEE, ANDREW H S, REED, JACQUIE, MURPHY, ALISON, EL-SAYED, MAYSA, BURRELL, HELEN, EVANS, ANDREW J and ELLIS, IAN O, 2010. Screen-detected malignant breast lesions diagnosed following benign (B2) or normal (B1) needle core biopsy diagnoses. European journal of cancer (Oxford, England : 1990). 46(10), 1835-40 BLOWS, F.M., DRIVER, K.E., SCHMIDT, M.K., BROEKS, A., LEEUWEN, F.E. VAN, WESSELING, J., CHEANG, M.C., GELMON, K., NIELSEN, T.O., BLOMQVIST, C., HEIKKILÄ, P., HEIKKINEN, T., NEVANLINNA, H., AKSLEN, L.A., BÉGIN, L.R., FOULKES, W.D., COUCH, F.J., WANG, X., CAFOUREK, V., OLSON, J.E., BAGLIETTO, L., GILES, G.G., SEVERI, G., MCLEAN, C.A., SOUTHEY, M.C. and RAKHA, E., 2010. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies PLoS Medicine. 7(5), e1000279 MARGINEAN, FELICIA, RAKHA, EMAD A, HO, BERNARD C, ELLIS, IAN O and LEE, ANDREW H S, 2010. Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 23(10), 1357-63 RAKHA, EMAD A, REIS-FILHO, JORGE S, BAEHNER, FREDERICK, DABBS, DAVID J, DECKER, THOMAS, EUSEBI, VINCENZO, FOX, STEPHEN B, ICHIHARA, SHU, JACQUEMIER, JOCELYNE, LAKHANI, SUNIL R, PALACIOS, JOSÉ and RI, 2010. Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast cancer research : BCR. 12(4), 207 ALESKANDARANY, MOHAMMED A, RAKHA, EMAD A, MACMILLAN, R DOUGLAS, POWE, DESMOND G, ELLIS, IAN O and GREEN, ANDREW R, 2010. MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups. Breast cancer research and treatment. RAKHA, EMAD A and ELLIS, IAN O, 2010. Lobular breast carcinoma and its variants. Seminars in diagnostic pathology. 27(1), 49-61 RAKHA, EMAD A, PATEL, ARJUN, POWE, DES G, BENHASOUNA, AHMED, GREEN, ANDREW R, LAMBROS, MARYOU B, REIS-FILHO, JORGE S and ELLIS, IAN O, 2010. Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast. The American journal of surgical pathology. 34(10), 1472-9 KWOK, T'NG CHANG, RAKHA, EMAD A, LEE, ANDREW H S, GRAINGE, MATTHEW, GREEN, ANDREW R, ELLIS, IAN O and POWE, DESMOND G, 2010. Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation. Histopathology. 57(2), 212-9 ALESKANDARANY, MOHAMMED A, RAKHA, EMAD A, AHMED, MOHAMED A, POWE, DESMOND G, ELLIS, IAN O and GREEN, ANDREW R, 2010. Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer. Breast cancer research and treatment. RAKHA, E.A., LEE, A.H.S., EVANS, A.J., MENON, S., ASSAD, N.Y., HODI, Z., MACMILLAN, D., BLAMEY, R.W. and ELLIS, I.O., 2010. Tubular carcinoma of the breast: further evidence to support its excellent prognosis Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 28(1), 99-104 RAKHA, EMAD A, LEE, ANDREW HS, JENKINS, JACQUIE A, MURPHY, ALISON E, HAMILTON, LISA J and ELLIS, IAN O, 2010. Characterisation and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. International journal of cancer. Journal international du cancer. RAKHA, EMAD A, REIS-FILHO, JORGE S and ELLIS, IAN O, 2010. Combinatorial biomarker expression in breast cancer. Breast cancer research and treatment. 120(2), 293-308 MUKHERJEE, A., SHEHATA, M., MOSELEY, P., RAKHA, E., ELLIS, I. and CHAN, S., 2010. Topo2α protein expression predicts the response to anthracycline combination neo-adjuvant chemotherapy in locally advanced breast cancer British Journal of Cancer. 103(12), 1794-1800 RAKHA EA, HAIDER A, PATIL S, FOURTAN H, CHAUDRY Z and SOOMRO IN, 2010. Evaluation Of Touch Preparation Cytology During Frozen-Section Diagnoses Of Pulmonary Lesions. Journal Of Clinical Pathology. 63(8), 675-7 RAKHA EA, PATIL S, ABDULLA K, ABDULKADER M, CHAUDRY Z and SOOMRO IN, 2010. The Sensitivity Of Cytologic Evaluation Of Pleural Fluid In The Diagnosis Of Malignant Mesothelioma. Diagnostic Cytopathology. 38(12), 874-9 RAKHA EA, NAIK V, CHAUDRY Z, BALDWIN D and SOOMRO IN, 2010. Cytological Assessment Of Conventional Transbronchial Fine Needle Aspiration Of Lymph Nodes. Cytopathology : Official Journal Of The British Society For Clinical Cytology. 21(1), 27-34 RAKHA EA, ADAMSON L, BELL E, NEAL K, RYDER SD, KAYE PV and AITHAL GP, 2010. Portal Inflammation Is Associated With Advanced Histological Changes In Alcoholic And Non-Alcoholic Fatty Liver Disease. Journal Of Clinical Pathology. 63(9), 790-5 PANG, Y., BALL, G., RAKHA, E., POWE, D., CALDAS, C., ELLIS, I and GREEN, A., 2010. SOX11 and PSMD3 Expression in HER2 Positive Breast Cancer JOURNAL OF PATHOLOGY. 222, S3-S3
CHEANG, MAGGIE C, HEIKKINEN, TUOMAS, GARCIA-CLOSAS, MONTSERRAT, GELMON, KAREN, CALDAS, CARLOS, NIELSEN, TORSTEN O, HUNTSMAN, DAVID, AKSLEN, LARS A, WANG, XIANSHU, COUCH, FERGUS J, BLOMQVIST, CARL, NEVANLINNA, HELI, MCLEAN, CATRIONA A, HEIKKILA, PAIVI, OLSON, JANET E, GILES, GRAHAM G, BAGLIETTO, LAURA, SEVERI, GIANLUCA, SOUTHEY, MELISSA C, ELLIS, IAN O, SCHMIDT, MARJANKA K, SHERMAN, MARK E, LISSOWSKA, JOLANTA, GREEN, ANDREW R, BROEKS, ANNEGIEN, BLOWS, FIONA M, DRIVER, KRISTY E, VAN LEEUWEN, FLORA E, WESSELING, JELLE, CROSS, SIMON S, REED, MALCOLM WR, BEGIN, LOUIS R, CAFOUREK, VICKY, RAKHA, EMAD, ANDERSON, WILLIAM F, PROVENZANO, ELENA, DAWSON, SARAH-JANE, HUMPHREYS, MANJEET, PHAROAH, PAUL D, DUNNING, ALISON M, COX, ANGELA, EASTON, DOUGLAS F and FOULKES, WILLIAM D, 2010. Figure_S7.eps. Figshare.
BENHASOUNA, A., GREEN, A., POWE, D., ALESKANDARANY, M., RAKHA, E. and ELLIS, I, 2010. PARP1 Expression in Hormone Estrogen Receptor Negative Breast Cancer: Preferential Expression in Basal-Like and HER2-Positive Tumours JOURNAL OF PATHOLOGY. 222, S8-S8
CHEANG, MAGGIE C, HEIKKINEN, TUOMAS, GARCIA-CLOSAS, MONTSERRAT, GELMON, KAREN, CALDAS, CARLOS, NIELSEN, TORSTEN O, HUNTSMAN, DAVID, AKSLEN, LARS A, WANG, XIANSHU, COUCH, FERGUS J, BLOMQVIST, CARL, NEVANLINNA, HELI, MCLEAN, CATRIONA A, HEIKKILA, PAIVI, OLSON, JANET E, GILES, GRAHAM G, BAGLIETTO, LAURA, SEVERI, GIANLUCA, SOUTHEY, MELISSA C, ELLIS, IAN O, SCHMIDT, MARJANKA K, SHERMAN, MARK E, LISSOWSKA, JOLANTA, GREEN, ANDREW R, BROEKS, ANNEGIEN, BLOWS, FIONA M, DRIVER, KRISTY E, VAN LEEUWEN, FLORA E, WESSELING, JELLE, CROSS, SIMON S, REED, MALCOLM WR, BEGIN, LOUIS R, CAFOUREK, VICKY, RAKHA, EMAD, ANDERSON, WILLIAM F, PROVENZANO, ELENA, DAWSON, SARAH-JANE, HUMPHREYS, MANJEET, PHAROAH, PAUL D, DUNNING, ALISON M, COX, ANGELA, EASTON, DOUGLAS F and FOULKES, WILLIAM D, 2010. Table_S4.doc. Figshare.
BAKER, B., BALL, G., RAKHA, E., POWE, D., CALDAS, C., ELLIS, I and GREEN, A., 2010. Candidate Molecular Markers as Correlates of the Basal Phenotype in Breast Cancer JOURNAL OF PATHOLOGY. 222, S3-S4
ELSHEIKH, S.E., GREEN, A.R., RAKHA, E.A., POWE, D.G., AHMED, R.A., COLLINS, H.M., SORIA, D., GARIBALDI, J.M., PAISH, C.E., AMMAR, A.A., GRAINGE, M.J., BALL, G.R., ABDELGHANY, M.K., MARTINEZ-POMARES, L., HEERY, D.M. and ELLIS, I.O., 2009. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome Cancer Research. 69(9), 3802-3809 GREEN, ANDREW R, YOUNG, PETER, KRIVINSKAS, SOPHIE, RAKHA, EMAD A, CLAIRE PAISH, E, POWE, DESMOND G and ELLIS, IAN O, 2009. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR. Histopathology. 54(4), 419-27 PAISH, E C, GREEN, A R, RAKHA, E A, MACMILLAN, R D, MADDISON, J R and ELLIS, I O, 2009. Three-dimensional reconstruction of sentinel lymph nodes with metastatic breast cancer indicates three distinct patterns of tumour growth. Journal of clinical pathology. 62(7), 617-23 RAKHA, EMAD A and ELLIS, IAN O, 2009. Triple-negative/basal-like breast cancer: review. Pathology. 41(1), 40-7 RAKHA, EMAD A, EL-SAYED, MAYSA E, REED, JACQUIE, LEE, ANDREW H S, EVANS, ANDREW J and ELLIS, IAN O, 2009. Screen-detected breast lesions with malignant needle core biopsy diagnoses and no malignancy identified in subsequent surgical excision specimens (potential false-positive diagnosis). European journal of cancer (Oxford, England : 1990). 45(7), 1162-7 AU-YONG, I T H, EVANS, A J, TANEJA, S, RAKHA, E A, GREEN, A R, PAISH, C and ELLIS, I O, 2009. Sonographic correlations with the new molecular classification of invasive breast cancer. European radiology. 19(10), 2342-8 RAKHA, E A, ALESKANDARANY, M, EL-SAYED, M E, BLAMEY, R W, ELSTON, C W, ELLIS, I O and LEE, A H S, 2009. The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. European journal of cancer (Oxford, England : 1990). 45(10), 1780-7 HAMILTON LJ, EVANS AJ, CORNFORD EJ, RAKHA EA, ELLIS IO and FOULKES WD, 2009. Will Mri Screening Deliver The Expected Survival Advantage In Brca 1 Carriers? Clinical Radiology. 64(11), 1045-7 RAKHA E and REIS-FILHO JS, 2009. Basal-Like Breast Carcinoma: From Expression Profiling To Routine Practice. Archives Of Pathology & Laboratory Medicine. 133(6), 860-8 RAKHA, E. A., ELSHEIKH, S. E., ALESKANDARANY, M. A., HABASHI, H. O., GREEN, A. R., POWE, D. G., EL-SAYED, M. E., BENHASOUNA, A., BRUNET, J. S., AKSLEN, L. A., EVANS, A. J., BLAMEY, R., REIS-FILHO, J. S., FOULKES, W. D. and ELLIS, I. O., 2009. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes: Clin Cancer Res Clin Cancer Res. 15(7), 2302-10 RAKHA, EMAD A., GILL, MUHAMMAD S., EL-SAYED, MAYSA E., KHAN, MARIUM M., HODI, ZSOLT, BLAMEY, ROGER W., EVANS, ANDREW J., LEE, ANDREW H. S. and ELLIS, IAN O., 2009. The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology BREAST CANCER RESEARCH AND TREATMENT. 114(2), 243-250 RAKHA, EMAD A, EL-SAYED, MAYSA E, POWE, DESMOND G, GREEN, ANDREW R, HABASHY, HANY, GRAINGE, MATTHEW J, ROBERTSON, JOHN F R, BLAMEY, ROGER, GEE, JULIA, NICHOLSON, ROBERT I, LEE, ANDREW H S and ELLIS, IAN, 2008. Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. European Journal of Cancer. 44(1), 73-83 FOULKES,, GRAINGE,, RAKHA,, GREEN, and ELLIS,, 2008. Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status. Breast Cancer Research and Treatment. 117(1), 199-204 RAKHA, E.A., EL-SAYED, M.E., LEE, A.H.S., ELSTON, C.W., GRAINGE, M.J., HODI, Z., BLAMEY, R.W. and ELLIS, I.O., 2008. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma Journal of Clinical Oncology. 26(19), 3153-3158 ELSHEIKH, S E, GREEN, A R, RAKHA, E A, SAMAKA, R M, AMMAR, A A, POWE, D, REIS-FILHO, J S and ELLIS, I O, 2008. Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. British journal of cancer. 99(2), 327-34
LUCK, ANGELA A, EVANS, ANDREW J, JAMES, JONATHAN J, RAKHA, EMAD A, PAISH, E CLAIRE, GREEN, ANDREW R and ELLIS, IAN O, 2008. Breast carcinoma with basal phenotype: mammographic findings. AJR. American journal of roentgenology. 191(2), 346-51
GREEN,, KRIVINSKAS,, YOUNG,, RAKHA,, PAISH,, POWE, and ELLIS,, 2008. Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast. Breast Cancer Research and Treatment. RAKHA, EMAD A, EL-SHEIKH, SOMAIA E, KANDIL, MONA A, EL-SAYED, MAYSA E, GREEN, ANDREW R and ELLIS, IAN O, 2008. Expression of BRCA1 protein in breast cancer and its prognostic significance. Human pathology. 39(6), 857-65 LUCK, A A, EVANS, A J, GREEN, A R, RAKHA, E A, PAISH, C and ELLIS, I O, 2008. The influence of Basal phenotype on the metastatic pattern of breast cancer. Clinical Oncology. 20(1), 40-5 HABASHY, HANY ONSY, POWE, DESMOND G, RAKHA, EMAD A, BALL, GRAHAM, PAISH, CLAIRE, GEE, JULIA, NICHOLSON, ROBERT I and ELLIS, IAN O, 2008. Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance. European Journal of Cancer. 44(11), 1541-51 RAKHA,, EL-SAYED,, REIS-FILHO, and ELLIS,, 2008. Patho-biological aspects of basal-like breast cancer. Breast Cancer Research and Treatment. RAKHA, EMAD A, REIS-FILHO, JORGE S and ELLIS, IAN O, 2008. Basal-like breast cancer: a critical review. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(15), 2568-81
RAKHA, EMAD A, REIS-FILHO, JORGE S and ELLIS, IAN O, 2008. Impact of basal-like breast carcinoma determination for a more specific therapy. Pathobiology : journal of immunopathology, molecular and cellular biology. 75(2), 95-103
RAKHA, EMAD A, ELLIS, IAN O and REIS-FILHO, JORGE S, 2008. Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas). Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 21(8), 1060-1; author reply 1061-2
TANEJA S, EVANS AJ, RAKHA EA, GREEN AR, BALL G and ELLIS IO, 2008. The Mammographic Correlations Of A New Immunohistochemical Classification Of Invasive Breast Cancer. Clinical Radiology. 63(11), 1228-35 TENNANT SL, EVANS A, HAMILTON LJ, JAMES J, LEE AHS, HODI Z, ELLIS IO, RAKHA EA and WILSON ARM, 2008. Vacuum-Assisted Excision Of Breast Lesions Of Uncertain Malignant Potential (B3) - An Alternative To Surgery In Selected Cases. Breast (Edinburgh, Scotland). 17(6), 546-9 RAKHA E, ELLIS I and REIS-FILHO J, 2008. Are Triple-Negative And Basal-Like Breast Cancer Synonymous? Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research. 14(2), 618; author reply 618-9 GREEN, A. R., BURNEY, C., GRANGER, C. J., PAISH, E. C., EL-SHEIKH, S., RAKHA, E. A., POWE, D. G., MACMILLAN, R. D., ELLIS, I. O. and STYLIANOU, E., 2008. Prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome BREAST CANCER RESEARCH. 10, S32-S32 EL-SAYED, MAYSA E., RAKHA, EMAD A., REED, JACQUIE, LEE, ANDREW H. S., EVANS, ANDREW J. and ELLIS, IAN O., 2008. Audit of performance of needle core biopsy diagnoses of screen detected breast lesions EUROPEAN JOURNAL OF CANCER. 44(17), 2580-2586 GREEN, ANDREW R., BURNEY, CLAIRE, GRANGER, CHRISTOPHER J., PAISH, E. CLAIRE, EL-SHEIKH, SOMAIA, RAKHA, EMAD A., POWE, DESMOND G., MACMILLAN, R. DOUGLAS, ELLIS, IAN O. and STYLIANOU, ELENI, 2008. The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome BREAST CANCER RESEARCH AND TREATMENT. 110(3), 427-437 ROLLAND, PHIL, SPENDLOVE, IAN, MADJID, ZAHRA, RAKHA, EMAD A, PATEL, POULAM, ELLIS, IAN O and DURRANT, LINDY, 2007. The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer. International Journal of Cancer. 120(6), 1311-7 RAKHA, E.A., EL-SAYED, M.E., GREEN, A.R., PAISH, E.C., POWE, D.G., GEE, J., NICHOLSON, R.I., LEE, A.H.S., ROBERTSON, J.F.R. and ELLIS, I.O., 2007. Biologic and clinical characteristics of breast cancer with single hormone receptor-positive phenotype. Journal of Clinical Oncology. 25(30), 4772-4778 RAKHA, EMAD A, EL-SAYED, MAYSA E, GREEN, ANDREW R, LEE, ANDREW H S, ROBERTSON, JOHN F and ELLIS, IAN O, 2007. Prognostic markers in triple-negative breast cancer. Cancer. 109(1), 25-32 RAKHA, E A, EL-SAYED, M E, GREEN, A R, PAISH, E C, LEE, A H S and ELLIS, I O, 2007. Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression. Histopathology. 50(4), 434-8 EVANS, A J, RAKHA, E A, PINDER, S E, GREEN, A R, PAISH, C and ELLIS, I O, 2007. Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up. Journal of Medical Screening. 14(4), 210-4 RAKHA,, EL-SAYED,, MENON,, GREEN,, LEE, and ELLIS,, 2007. Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast. Breast Cancer Research and Treatment. RAKHA, EMAD A, TAN, DAVID SP, FOULKES, WILLIAM D, ELLIS, IAN O, TUTT, ANDREW, NIELSEN, TORSTEN O and REIS-FILHO, JORGE S, 2007. Are triple-negative tumours and basal-like breast cancer synonymous? Breast cancer research : BCR. 9(6), 404
EL-SHEIKH, S.E., GREEN, A.R., RAKHA, E.A., PAISH, E.C., HEERY, D.M. and ELLIS, I.O., 2007. Global histone modifications in breast cancer and their prognostic significance Modern Pathology. 20, 29A-30A
EL-SHEIKH, S.E., GREEN, A.R., RAKHA, E.A., PAISH, E.C., HEERY, D.M. and ELLIS, I.O., 2007. Global histone modifications in breast cancer and their prognostic significance Laboratory Investigation. 87, 29A-30A
RAKHA EA, KANDIL MA and EL-SANTAWE MG, 2007. Gigantic Recurrent Abdominal Desmoid Tumour: A Case Report. Hernia : The Journal Of Hernias And Abdominal Wall Surgery. 11(2), 193-7 ELSHEIKH, S., GREEN, A. R., RAKHA, E., SAMAK, R. and ELLIS, I. O., 2007. UPARAP/ENDO180 expression in invasive breast carcinoma and its relation to patient outcome EJC SUPPLEMENTS. 5(3), 28-28 LUCK, A. A., EVANS, A. J., RAKHA, E. A., GREEN, A. R., PAISH, C. and ELLIS, I. O., 2007. Breast cancer with basal phenotypic expression: mammographic findings EJC SUPPLEMENTS. 5(3), 9-9 RAKHA, E.A., PUTTI, T.C., ABD EL-REHIM, D.M., PAISH, C., GREEN, A.R., POWE, D.G., LEE, A.H., ROBERTSON, J.F. and ELLIS, I.O, 2006. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation Journal of Pathology. 208(4), 495-506 RAKHA, EMAD A, EL-REHIM, DALIA ABD, PAISH, CLAIRE, GREEN, ANDREW R, LEE, ANDREW H S, ROBERTSON, JOHN F, BLAMEY, ROGER W, MACMILLAN, DOUGLAS and ELLIS, IAN O, 2006. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. European Journal of Cancer. 42(18), 3149-56 RAKHA, E.A., GREEN, A.R., POWE, D.G., ROYLANCE, R. and ELLIS, I.O, 2006. Chromosome 16 tumor-suppressor genes in breast cancer. Genes, Chromosomes & Cancer. 45(6), 527-535 GREEN, A.R., EL-SHEIKH, S., RAKHA, E.A., PAISH, E.C., HEERY, D.M. and ELLIS, I.O., 2006. Global histone modifications in breast cancer and their prognostic significance Breast Cancer Research. 8, S16-S16 EL-SHEIKH, S., RAKHA, E.A., PAISH, E.C., HEERY, D.M. and SALOMONI, P., 2006. Global histone modifications in breast cancer and their prognostic significance Journal of Pathology. 210, 1-1
RAKHA EA, PUTTI TC, ABD EL-REHIM DM, PAISH C, GREEN AR, POWE DG, LEE AH, ROBERTSON JF and ELLIS IO, 2006. Morphological And Immunophenotypic Analysis Of Breast Carcinomas With Basal And Myoepithelial Differentiation. The Journal Of Pathology. 208(4), 495-506 RAKHA E, PULS F, SAIDUL I and FURNESS P, 2006. Torsion Of The Testicular Appendix: Importance Of Associated Acute Inflammation. Journal Of Clinical Pathology. 59(8), 831-4 RAKHA E, RAMAIAH S and MCGREGOR A, 2006. Accuracy Of Frozen Section In The Diagnosis Of Liver Mass Lesions. Journal Of Clinical Pathology. 59(4), 352-4 EL SHEIKH, S., RAKHA, E. A., PAISH, E. C., HEERY, D. M., GREEN, A. R. and ELLIS, I. O., 2006. Global histone modifications in breast cancer and their prognostic significance JOURNAL OF PATHOLOGY. 210, 1-1
RAKHA, EA, PUTTI, TC, EL-REHIM, DMA, PAISH, C, GREEN, AR, POWE, DG, LEE, AH, ROBERTSON, JF and ELLIS, IO, 2006. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation JOURNAL OF PATHOLOGY. 208(4), 495-506 RAKHA, EMAD A, ARMOUR, JOHN A L, PINDER, SARAH E, PAISH, CLAIRE E and ELLIS, IAN O, 2005. High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry. International Journal of Cancer. 114(5), 720-9 RAKHA, E A, ABD EL REHIM, D, PINDER, S E, LEWIS, S A and ELLIS, I O, 2005. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology. 46(6), 685-93 KURIEN T, BOYCE RWG, PAISH EC, RONAN J, MADDISON J, RAKHA EA, GREEN AR and ELLIS IO, 2005. Three Dimensional Reconstruction Of A Human Breast Carcinoma Using Routine Laboratory Equipment And Immunohistochemistry. Journal Of Clinical Pathology. 58(9), 968-72 RAKHA EA, BOYCE RWG, ABD EL-REHIM D, KURIEN T, GREEN AR, PAISH EC, ROBERTSON JFR and ELLIS IO, 2005. Expression Of Mucins (Muc1, Muc2, Muc3, Muc4, Muc5ac And Muc6) And Their Prognostic Significance In Human Breast Cancer. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc. 18(10), 1295-304 PUTTI TC, EL-REHIM DMA, RAKHA EA, PAISH CE, LEE AHS, PINDER SE and ELLIS IO, 2005. Estrogen Receptor-Negative Breast Carcinomas: A Review Of Morphology And Immunophenotypical Analysis. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc. 18(1), 26-35 RAKHA E, MAYNE C and BROWN L, 2005. Mucinous Metaplasia Of The Vulva In A Case Of Lichen Sclerosus. A Case Report. Journal Of Clinical Pathology. 58(11), 1217-8 RAMAIAH, S, RAKHA, E, WEST, K and MCGREGOR, A, 2005. A scoring system for reporting frozen section of hepatobiliary and pancreatic lesions JOURNAL OF PATHOLOGY. 207, 28-28